Evidence map›Paper›PMID 23892485›Full record

ArticleJournal of materials science. Materials in medicine2013

Tetracycline-encapsulated P(3HB) microsphere-coated 45S5 Bioglass(®)-based scaffolds for bone tissue engineering.

D Meng, L Francis, I D Thompson, C Mierke, H Huebner, A Amtmann, I Roy, A R Boccaccini

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Biocompatible MgFeCOBioengineering (Basel, Switzerland) · 2023
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Microsphere-Based Scaffolds in Regenerative Engineering.Annual review of biomedical engineering · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

D MengDepartment of Materials, Imperial College London, London, SW7 2BP, UK.
L Francis
I D Thompson
C Mierke
H Huebner
A Amtmann
I Roy
A R Boccaccini
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEImperial College London · GBUniversity of Westminster · GBKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioglass(®)-based scaffolds for bone tissue engineering have been developed, which can also serve as carriers for drug delivery. For this, P(3HB) microspheres (PMSs) loaded with tetracycline were fabricated and immobilised on the scaffold surfaces by a modified slurry dipping technique. The sustained drug delivery ability in simulated body fluid was confirmed by using UV-Vis absorption spectroscopy measurements. The MTT assay using mouse fibroblast cells provided evidence that the tetracycline loaded microspheres produced in this study show limited cytotoxicity. The scaffolds developed in this work provide mechanical support, adequate 3D surface roughness, bioactivity and controlled drug delivery function, and are thus interesting candidates for bone tissue engineering applications.

Indexed as

MicrospheresAnimalsAnti-Bacterial AgentsBone and BonesBone SubstitutesCeramicsCoated Materials, BiocompatibleDrug CarriersDrug Delivery SystemsFibroblastsGlassMaterials TestingMiceTetracyclineTetrazolium SaltsThiazolesAnti-Bacterial Agentsbioactive glass 45S5Bone SubstitutesCoated Materials, BiocompatibleDrug CarriersTetracyclineTetrazolium SaltsThiazolesthiazolyl blue

Identifiers

PMID23892485
OpenAlexW2051827248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.